Trial Outcomes & Findings for Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics (NCT NCT01450787)

NCT ID: NCT01450787

Last Updated: 2013-09-30

Results Overview

Conjunctival staining with lissamine green dye is measured at the time of the evaluation on a scale from 0 to 5 using the oxford scoring system, with 5 being the most severe staining.

Recruitment status

TERMINATED

Target enrollment

63 participants

Primary outcome timeframe

at the time of the evaluation

Results posted on

2013-09-30

Participant Flow

Subjects were enrolled randomly. Consecutive patients in a private ophthalmology clinic that met inclusion criteria were asked to participate at the time of an already scheduled exam. The non-diabetic group recruitment stopped once the target number of subjects enrolled. The diabetic group recruitment continued until the study was terminated.

Being that there was no intervention and the study only involved taking measurements at the time of the exam, there was no transition required. Any eligible patient that was willing to participate was included. Consecutive diabetic patients and consecutive non-diabetic patients that met criteria were offered the opportunity to enroll.

Participant milestones

Participant milestones
Measure
Diabetics
diabetics over age 40
Non Diabetics
non diabetics over age 40
Overall Study
STARTED
38
25
Overall Study
COMPLETED
38
25
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Prevalence of Dry Eyes in Diabetics Compared to Non Diabetics

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Diabetics
n=38 Participants
diabetics over age 40
Non Diabetics
n=25 Participants
non diabetics over age 40
Total
n=63 Participants
Total of all reporting groups
Age, Customized
38 participants
n=5 Participants
25 participants
n=7 Participants
63 participants
n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
21 Participants
n=7 Participants
43 Participants
n=5 Participants
Sex: Female, Male
Male
16 Participants
n=5 Participants
4 Participants
n=7 Participants
20 Participants
n=5 Participants
Region of Enrollment
United States
38 participants
n=5 Participants
25 participants
n=7 Participants
63 participants
n=5 Participants

PRIMARY outcome

Timeframe: at the time of the evaluation

Population: There were 38 consecutive diabetics over 40 years of age and 25 consecutive non-diabetics over 40 years of age that qualified and agreed to enroll. A target of 25 non-diabetics was met. The target of 50 was not met as the study was stopped when the PI changed practices. By that time, 38 diabetics enrolled.

Conjunctival staining with lissamine green dye is measured at the time of the evaluation on a scale from 0 to 5 using the oxford scoring system, with 5 being the most severe staining.

Outcome measures

Outcome measures
Measure
Diabetics
n=38 Participants
diabetics over age 40
Non Diabetics
n=50 eyes
non diabetics over age 40
Conjunctival Staining Score
2.72 units on a scale
Standard Error 0.16
2.19 units on a scale
Standard Error 0.19

SECONDARY outcome

Timeframe: at the time of the exam

Population: Tear film osmolarity was measured in all patients, but two patients in the diabetic group had an insufficient tear film to obtain a reading. Therefore, only 36 diabetics were included.

The tear film osmolarity is measured at the time of the exam.

Outcome measures

Outcome measures
Measure
Diabetics
n=72 eyes
diabetics over age 40
Non Diabetics
n=50 eyes
non diabetics over age 40
Tear Film Osmolarity
303.41 mOsml/L
Standard Error 2.03
312.06 mOsml/L
Standard Error 3.05

OTHER_PRE_SPECIFIED outcome

Timeframe: at the time of the exam

Population: All patients completed the OSDI survey

The ocular surface disease index survey in completed at the time of the exam. This scale ranges from 0 to 100 higher scores representing greater disability.

Outcome measures

Outcome measures
Measure
Diabetics
n=38 Participants
diabetics over age 40
Non Diabetics
n=25 Participants
non diabetics over age 40
OSDI Score
19.58 units on a scale
Standard Error 2.62
27.50 units on a scale
Standard Error 4.60

OTHER_PRE_SPECIFIED outcome

Timeframe: at the time of the exam

Population: Each patient underwent schirmer testing

The schirmer tear production test with anesthesia is completed at the time of the exam in mm of tear film absorption on the test strip after five minutes. Higher scores represent greater tear production.

Outcome measures

Outcome measures
Measure
Diabetics
n=76 eyes
diabetics over age 40
Non Diabetics
n=50 eyes
non diabetics over age 40
Schirmer Score
18.36 mm
Standard Error 1.06
15.88 mm
Standard Error 1.34

OTHER_PRE_SPECIFIED outcome

Timeframe: at the time of the exam

Population: Each patient underwent tear break-up time testing

The tear break-up time with fluorescein solution is measured at the time of the exam in seconds.

Outcome measures

Outcome measures
Measure
Diabetics
n=76 eyes
diabetics over age 40
Non Diabetics
n=50 eyes
non diabetics over age 40
Tear Break-up Time
3.38 seconds
Standard Error 0.17
3.66 seconds
Standard Error 0.26

OTHER_PRE_SPECIFIED outcome

Timeframe: at the time of the exam

Population: All patients underwent corneal staining evaluations using fluorescein.

Corneal staining with fluorescein solution is graded at the time of the exam on a scale of 0 to 5 using the oxford scoring system with 5 being the most severe staining.

Outcome measures

Outcome measures
Measure
Diabetics
n=76 eyes
diabetics over age 40
Non Diabetics
n=50 eyes
non diabetics over age 40
Corneal Staining
0.31 units on a scale
Standard Error 0.08
0.30 units on a scale
Standard Error 0.13

Adverse Events

Diabetics

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Non Diabetics

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Kenneth A Beckman, MD

Coa Research Foundation

Phone: 614-506-4720

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place